Finally, it was found that blocking PD-L1/PD-1 interactions selectively interfered with these inhibitory Treg–T effector cell interactions, resulting in enhanced antitumor activity even against tumor cells lacking checkpoint inhibitor expression [230]. Here, PDCD1 is linked to neoplasm.